The Clinical Relevance of Partial Agonist Activity of Beta-Adrenoceptor Blocking Drugs
Beta-adrenoceptor blocking drugs are often considered first choice therapy in patients with mild hypertension who require medical therapy. This is due not only to their effectiveness but also to the low incidence of side-effects during long-term administration.
KeywordsCardiac Output Clinical Pharmacology Peripheral Resistance Rest Heart Rate Haemodynamic Effect
Unable to display preview. Download preview PDF.
- Aellig, W. H., 1979, Nagra kliniskt farmakologiska experiment med β-adrenoceptorblockerande farmaka, in: 3. Basel Hypertoni Saposiet, pp.29–33, L. Hansson and O. Thulesius, eds.Google Scholar
- Prichard, B. N. C., Bhattacharjee, P., Tomlinson, B., and Waiden, R. J., 1982, The withdrawal of β-adrenergic blocking drugs, (same volume).Google Scholar
- Schlüter, K. J., Aellig, W. H., Petersen, K.-G., Rieband, H.-Ch., Wehrli, A., and Kerp, L., 1982, The influence of β-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia, Br.J.Clin.Pharmac., 13:407–417S.CrossRefGoogle Scholar
- Simpson, F. O., and Waal-Manning, H. J., 1970, Hypertension and β-adrenergic blockade, New Horizons Med., 1:59–72.Google Scholar